• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Aratana Files for FDA Approval of Label Expansion

June 8, 2018
American Veterinarian Editorial Staff

If approved, the label expansion would make Nocita available for use as a peripheral nerve block in cats.

Aratana Therapeutics, Inc., a company focused on innovative therapeutics for dogs and cats, announced earlier this month that it had filed for a label expansion with the US Food and Drug Administration's (FDA) Center for Veterinary Medicine for Nocita (bupivacaine liposome injectable suspension), a long-acting, local anesthetic that provides up to 72 hours of postoperative analgesia.

Currently, the product is approved for use in dogs to provide local postoperative analgesia for cranial cruciate ligament surgery. If the expansion is accepted, Nocita would be available for use in cats as a peripheral nerve block to provide regional postoperative analgesia following onychectomy.

"We believe veterinarians are in need of safe and effective, non-opioid alternatives to provide pain relief to their feline and canine patients," Ernst Heinen, DVM, PhD, chief development officer of Aratana Therapeutics, said.

Advertisement

The FDA’s review date is set for July 30.

Aratana made headlines earlier this year when its canine osteosarcoma vaccine, Live Listeria Vector (AT-014), was granted a conditional license by the US Department of Agriculture (USDA) Center for Veterinary Biologics. The vaccine uses a Listeria-based antigen delivery system that activates cytotoxic T cells.

As part of an extended field study, the vaccine was made available for purchase at approximately 24 veterinary oncology practice groups across the United States. If results of the new study are successful, the USDA may approve the vaccine and allow unrestricted sales throughout the United States.


Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement